Difference between revisions of "Villegas VE, et al. Int. J. Mol. Sci. (2016) cited as Ref 223 in DOI: 10.1038/s41392-020-0110-5 (Q9486)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 17, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 308-, #quickstatements; #temporary_batch_1590074839150) |
||
(One intermediate revision by the same user not shown) | |||
Property / title | |||
+ | Tamoxifen treatment of breast cancer cells: impact on hedgehog/GLI1 signaling (English) | ||
Property / title: Tamoxifen treatment of breast cancer cells: impact on hedgehog/GLI1 signaling (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 308- | ||
Property / Page(s): 308- / rank | |||
+ | Normal rank |
Latest revision as of 15:34, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Villegas VE, et al. Int. J. Mol. Sci. (2016) cited as Ref 223 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Villegas VE
0 references
2016
0 references
Int. J. Mol. Sci.
0 references
17
0 references
Tamoxifen treatment of breast cancer cells: impact on hedgehog/GLI1 signaling (English)
0 references
308-
0 references